DOI: 10.1055/s-00000025

Hormone and Metabolic Research

LinksSchließen

Referenz

Kroiss M, Megerle F, Kurlbaum M. et al.
Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib.

J Clin Endocrinol Metab 2020; 105 dgz318

Bibliographische Angaben herunterladen

Suchen in: